Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.

Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K, Gomes S, Liu Y, Abe MK, Nor JE, Lingen MW, Rosner MR.

Blood. 2009 Nov 12;114(20):4592-600. doi: 10.1182/blood-2009-04-217042. Epub 2009 Aug 26.

2.

Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth.

Mirochnik Y, Aurora A, Schulze-Hoepfner FT, Deabes A, Shifrin V, Beckmann R, Polsky C, Volpert OV.

Clin Cancer Res. 2009 Mar 1;15(5):1655-63. doi: 10.1158/1078-0432.CCR-08-2113. Epub 2009 Feb 17.

3.

PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.

Veliceasa D, Schulze-Hoëpfner FT, Volpert OV.

PPAR Res. 2008;2008:945275. doi: 10.1155/2008/945275. Epub 2008 Nov 18.

4.

Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.

Smith ND, Schulze-Hoepfner FT, Veliceasa D, Filleur S, Shareef S, Huang L, Huang XM, Volpert OV.

J Urol. 2008 Jun;179(6):2427-34. doi: 10.1016/j.juro.2008.01.081. Epub 2008 Apr 23.

Supplemental Content

Loading ...
Support Center